Physician profile
Stephanie Steele
NPI 1164126017
$3,929.85
in general payments reported to CMS, 2019-2025
23 companies · $626 in 2025
The $626 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $758 · 2024: $2,545 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,721 · Travel and Lodging: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,720.99 |
| Travel and Lodging | $1,208.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,053.52 | 2023-2024 | Axonics |
| Antares Pharma, INC. | $263.60 | 2024-2025 | Xyosted |
| Myriad Genetic Laboratories, INC. | $229.05 | 2023 | Prolaris |
| Janssen Biotech, INC. | $199.66 | 2023-2025 | Erleada, Akeega |
| Coloplast Corp | $182.29 | 2023-2025 | Restorelle, Saffron |
| Urogen Pharma, INC. | $157.66 | 2023-2025 | Jelmyto |
| Boston Scientific Corporation | $123.21 | 2024-2025 | Solyx Sis System, Ams 700, Axonics |
| Photocure INC | $112.56 | 2023-2025 | Cysview |
| Tolmar, INC. | $96.00 | 2024-2025 | Jatenzo, Eligard |
| Abbvie INC. | $83.13 | 2024-2025 | |
| 180 Medical, INC. | $79.02 | 2023-2025 | Gentlecath Glide |
| Halozyme INC | $66.08 | 2023 | |
| Sumitomo Pharma America, INC. | $39.32 | 2023 | Gemtesa |
| Innovation Technologies INC | $38.99 | 2024 | Irrisept |
| Olympus America INC. | $32.26 | 2023 | Itind System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $26.39 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.47 | 2025 | |
| Pfizer INC. | $22.52 | 2025 | |
| Accord Healthcare, INC. | $22.44 | 2023 | |
| Progenics Pharmaceuticals, INC. | $21.73 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $19.39 | 2023 | Bard Urinary Drainage Bag |
| Abc Home Medical Supply, INC. | $17.78 | 2024 | |
| Hollister Incorporated | $17.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.